Exclusive: CBMG CEO Talks Stem-Cell Therapies, Cancer Treatments, Financials & The Chinese Market – Benzinga
Benzinga |
Exclusive: CBMG CEO Talks Stem–Cell Therapies, Cancer Treatments, Financials & The Chinese Market
Benzinga One is an immune cell therapy aimed at the treatment of a broad range of cancers using Cancer Vaccines, Chimeric Antigen Receptor T cell (“CAR-T”) and anti-PD-1 Technologies. The other one uses stem cells for regenerative purposes; the key indication … This simple method can predict a stem cell’s fateFuturity: Research News Live stem cell imaging technique opens new windows into pancreatic regenerationDiabetes.co.uk Global Stem Cell Therapy Consumption 2016 Market Research ReportMedgadget (blog) ScienceBlog.com (blog) –Bristol Observer (registration) –MedPage Today all 12 news articles » |
OCRegister |
Is Alzheimer’s treatment of injecting stem cells into the brain a breakthrough or quackery?
OCRegister Turner has written extensively and critically about the Cell Surgical Network (CSN), for which Duma, whose home hospital is Hoag in Newport Beach, is listed as a network physician. The CSN promotes “the stem cell revolution,” which its literature … |
CNN |
Sickle cell anemia patient ‘cured’ by gene therapy, doctors say
CNN Leboulch and his colleagues are using the same genetic therapy to treat a similar disease called thalassemia, another inherited blood disorder in which patients have less hemoglobin and fewer red blood cells than normal. Severe forms require regular … Sickle cell anemia patient ‘cured’ by gene therapy, doctors say …FOX31 Denver Sickle cell gene therapy: ‘It gives me joy and hope’BBC News Gene therapy shows early promise against sickle cellChicago Tribune Fox News –BBC News –New England Journal of Medicine all 79 news articles » |
University of California |
Gene therapy offers hope for newborns with severe immune disorder
University of California Infants born with a type of the devastating immune disorder SCID, or “bubble boy disease,” may have the option of a novel gene therapy treatment, thanks to a clinical trial at UCSF Benioff Children’s Hospital San Francisco. The trial is funded by a … |
Medscape |
Juno Permanently Halts CAR T-Cell Study
Medscape The CAR T-cell approach, which involves taking T-cells from patients, engineering them, and then reinfusing them back into the patient, has produced dramatic results in clinical trials in leukemia and lymphoma patients. However, clinical trials with … Juno Halts Development of CAR T-Cell Cancer Immunotherapy Candidate JCAR015Genetic Engineering & Biotechnology News (press release) Juno ditches lead CAR–T program following patient deathsFierceBiotech After Trial Deaths, Juno Pivots and Scraps Lead CAR–T TherapyXconomy PMLiVE –Endpoints News –OncLive all 91 news articles » |